Skip to content

Comparison effect of Carbetocine and Syntometrin in prevention of post partum hemorrhage

Comparison effect of Carbetocine and Syntometrin in prevention of post partum hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138810212854N2
Enrollment
200
Registered
2010-03-15
Start date
2010-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post partum hemorrhage. Postpartum care and examination

Interventions

Intervention 1: Syntometrin, 1 ml, IM in third stage of labour after placental expulsion. Intervention 2: Carbetocin, 1 ml, IM in third stage of labour.
Prevention
Carbetocin, 1 ml, IM in third stage of labour

Sponsors

Vice Chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: pregnant women with single pregnancy and candidate for vaginal delivery Exclusion criteria: Presence of preeclampsia, hypotension, heart disease, asthma, hypertonic uterus, uterine rupture, or vaginal and cervical laceration, being high risk for postpartum bleeding such as: multiparity, uterine myoma, history of postpartum bleeding, or need for uterine curettage.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Uterine tone. Timepoint: 0.5 and 1 hours after delivery. Method of measurement: Assessment of uterine tone.;Hemoglobin level. Timepoint: Before and 24 hours after delivery. Method of measurement: Hemoglobine assessment.

Secondary

MeasureTime frame
Need to adminestration of utertonic drug. Timepoint: During 24 hours after delivery. Method of measurement: dosage and amount of drug.;Adverse effects. Timepoint: During Hospitalization. Method of measurement: Observation of adverse effects.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Abedzadeh kalahroudi

Kashan University of Medical Sciences

abedzadeh@kaums.ac.irabed_m2004@yahoo.com+98 36 1555 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026